Our results suggest that overexpression of CD44s could be relevant in determining the highly invasive behaviour of gliomas, though it does not behave as an independent prognostic factor for survival.
The expression of E-cadherin and TIMP-2 could be relevant in determining the prognosis of CRC patients and providing a more accurate mechanism for their classification.
Background: CEACAM1, a novel target for cancer immunotherapy, is a member of the CEA family; it contains an immunoreceptor tyrosine-based inhibition motif (ITIM) in the intra-cytoplasmic domain. The ITIM motif appears to function in immune tolerance and immune exhaustion. Consequently, it plays a crucial role in inhibitory signals to immune cells. CEACAM1 is expressed on the membrane of T cells, NK cells, TILs, and tumor cells, and is known for the homophilic interaction with CEACAM1 expressed on tumor cells or immunocytes. We developed MG1124, a fully human monoclonal antibody against CEACAM1. abstracts Annals of Oncology Volume 31 -Issue S4 -2020 S725
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.